ÂÜÀòÂÒÂ×

Luke Elliott is a Senior Team Leader at Liverpool ChiroChem (LCC) since July 2021, overseeing the development and production of novel chiral sp3 rich scaffolds for drug discovery. Prior to this role, Luke served as a Postdoctoral Research Associate at the University of Bristol from December 2011 to June 2021, working on various collaborative projects that focused on transforming chemical synthesis and developing novel manufacturing techniques in partnership with several universities and major industrial players such as AstraZeneca and Novartis. Luke holds a Doctor of Philosophy (PhD) in Organic Chemistry and an MSci in Chemistry from the University of Bristol, along with A-levels in Maths, Further Maths, Physics, and Chemistry from Hereford Sixth Form College.